UARK 2005-05, Coagulation-Related Effects of Velcade Treatment in Patients With Relapsed or Refractory Multiple Myeloma
NCT00569868
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
MULTIPLE MYELOMA
Interventions
DRUG:
Velcade
Sponsor
University of Arkansas